Intervention

ALVAC-HIV

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting0

Common conditions2

Lead sponsors shown3

Clinical trials

4 shown

A Safety and Immune Response Study of 2 Experimental HIV VaccinesNCT02404311 · 2015-02-02

COMPLETED

Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/ENCT01931358 · 2013-09-24

UNKNOWN

Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy AdultsNCT02109354 · 2013-06-18

COMPLETED

Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144NCT01435135 · 2012-04-01

UNKNOWN

Common conditions

HIV Infection2 HIV Infections2

Leading sponsors

U.S. Army Medical Research and Development Command2 HIV Vaccine Trials Network1 National Institute of Allergy and Infectious Diseases (NIAID)1

Trial status mix

COMPLETED2

UNKNOWN2

Phase mix

PHASE23

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.